COVID-19 Resources for Blood Donor Centers
Developed with input from federal regulators, AABB’s regulatory resources are clear, user-friendly tools that help blood centers and transfusion services protect donor and patient safety at each step in the transfusion chain.
Reporting Fatalities Related to Blood Transfusion and Donation to FDA
REGULATORY UPDATE: New AABB-BCA Toolkit Focuses on Shared Manufacturing as a Cybersecurity Strategy
April 09, 2025
REGULATORY UPDATE: AABB, ABC and ARC Ask FDA to Reconsider HTLV-I/II Testing Recommendations
April 09, 2025
REGULATORY UPDATE: AABB, ABC and ARC Submit Comments to FDA on Mtb and Sepsis Guidances
April 08, 2025